Location permission needed for a better experience.
How can we help you?
EN
Hızlı Randevu
Hastane
Randevusu
Görüntülü Görüşme Randevusu

Profesör veya doçent doktor tercihinizde öğretim üyesi farkı oluşabilir. Ayrıca kurumlara ait uygulama esasları farklılık gösterebilir.

Education
  • 2017 İleri Endoskopi ve Motilite, Academic Medical Center, Amsterdam Hollanda
  • 2014 University of Michigan, Division of Gastroenterology and Hepatology, Ann Arbor, MI, ABD / Hepatology Research Fellowship
  • 2012 Ege University Faculty of Medicine Gastroenteroloji
  • 2008 Marmara University Faculty of Medicine İç Hastalıkları
  • 2001 İstanbul University Cerrahpaşa Faculty of Medicine
Experience
  • 2012 - 2014 University of Michigan, Division of Gastroenterology and Hepatology, Ann Arbor, MI, ABD
  • 2009 - 2012 Ege University Faculty of Medicine Gastroenteroloji Department
  • 2008 - 2009 Haydarpaşa Numune Eğitim ve Araştırma Hospital, Gastroenteroloji Bölümü
  • 2008 Acıbadem Healthcare Services
  • 2002 - 2008 Marmara University Faculty of Medicine İç Hastalıkları Department
Memberships
  • American Gastroenterology Association
  • American Association for the Study of Liver Disease
  • European Association for the Study of Liver Disease
  • Türk Karaciğer Araştırmaları Association
  • Türk Gastroenteroloji Association
  • Ulusal İnflamatuvar Barsak Hastalıkları Association
PUBLICATIONS
  • Management of Hepatitis B: My Practice and How it Relates to the Guidelines. Clin Gastroenterol Hepatol 2014;12(1):16-26. Yapali S, Talaat N, Lok AS.
  • Outcome of chronic hepatitis B patients who do not meet criteria for antiviral treatment at presentation. Clin Gastroenterol Hepatol 2014 Jul 17. pii: S1542- 3565(14)01048-9. doi: 10.1016/j.cgh.2014.07.019. Yapali S, Talaat N, Fontana RJ, Oberhelman K, Lok AS.
  • The potential benefit of telbivudine does not outweigh its high rate of antiviral drug resistance and other adverse effects. Gastroenterology 2014;146(1)15-9. Yapali S, Lok AS.
  • Does suppression of HBV replication by antiviral therapy confer the same benefit as host immune control of HBV? Gut 2014, Apr 1. doi: 10.1136/gutjnl-2014-306935. Yapali S, Lok AS.
  • Should this patient be treated? Best practices in identifying cirrhosis and HCC in patients infected with HBV ? Role of prediction models. Johns Hopkins Medicine eViralHepatitis Review 2012, Volume 3, Issue 3. Yapali S, Lok AS.
.
.
.

Contact Us

Fill out the form below for your information requests

As Acıbadem Healthcare Group, you can report your requests, suggestions, thanks and complaints by filling out the form below or by contacting us at +90 538 685 39 52 so that we can provide you with a better and higher quality service.

See More
See More
Security Code

INFORMATION NOTICE ON THE PROCESSING OF PERSONAL DATA

Acıbadem Sağlık Hizmetleri ve Ticaret A.Ş. and its controlling and affiliated companies listed in Annex-1 (each referred to individually as the "Company" and collectively as the "Companies") process your general and/or special category personal data (including but not limited to health data) ("Personal Data") in the capacity of Data Controller under the Personal Data Protection Law No. 6698 ("Law") and related legislation. Processing of Personal Data is carried out in accordance with the framework outlined below and in compliance with the Fundamental Law on Health Services No. 3359, the Decree Law No. 663 on the Organization and Duties of the Ministry of Health and its Affiliated Institutions, the Regulation on the Provision of Remote Health Services, the Private Hospitals Regulation, the Ministry of Health regulations, and other relevant legislation.

I. Acquisition, Processing, and Purposes of Processing Personal Data

Your Personal Data is obtained through verbal, written, visual, or electronic channels (such as our website, mobile applications, and call center) for the purposes of protecting public health, preventive medicine, medical diagnosis, treatment and care services, and the planning and management of healthcare services and their financing, in alignment with the Company's fields of activity. The Personal Data processed by the Company, including but not limited to the following, is collected and processed proportionally and in connection with these purposes:

Your Personal Data may be processed under the conditions specified in Articles 5 and 6 of the Law for the following purposes:

II. Transfer of Personal Data

Your Personal Data may be shared with:

III. Method and Legal Basis for Collecting Personal Data

Your Personal Data is collected through verbal, written, visual, or electronic means for the lawful execution of the Company's activities and compliance with contractual and legal obligations. The legal basis for collection includes:

As per Article 6 - (3) of the Law, personal data related to health and sexual life may be processed without explicit consent by persons or institutions subject to confidentiality obligations for public health protection, preventive medicine, medical diagnosis, treatment, and care services, as well as the planning and management of healthcare financing.

IV. Your Rights Regarding the Protection of Personal Data

Under Article 11 of the Law, you have the right to:

V. Data Security

The Companies ensure the security of Personal Data by implementing necessary technical and administrative measures in accordance with information security standards and procedures.

VI. Complaints and Contact Information

To exercise your rights under the Law, you may submit a request through the methods specified in the "Acıbadem Sağlık Hizmetleri ve Ticaret A.Ş. Data Subject Application Form" available at https://www.acibadem.com.tr/acibademonline/images/Ac%C4%B1badem_Veri_Sahibi_Basvuru_Formu.pdf.

Requests can be submitted by mail, notarized document, or secure electronic means to:

ANNEX-1: List of Companies

 

TOP x""